HomeELTX • NASDAQ
add
Elicio Therapeutics Inc
Previous close
$8.08
Day range
$7.95 - $8.13
Year range
$4.60 - $12.62
Market cap
140.27M USD
Avg Volume
108.52K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 8.04M | -22.23% |
Net income | -10.08M | 46.48% |
Net profit margin | — | — |
Earnings per share | -0.60 | 56.83% |
EBITDA | -8.00M | 22.14% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 20.61M | -20.78% |
Total assets | 28.28M | -26.32% |
Total liabilities | 24.47M | -57.35% |
Total equity | 3.82M | — |
Shares outstanding | 17.48M | — |
Price to book | 36.73 | — |
Return on assets | -69.58% | — |
Return on capital | -112.96% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -10.08M | 46.48% |
Cash from operations | -11.09M | -52.41% |
Cash from investing | — | — |
Cash from financing | 9.57M | -68.88% |
Net change in cash | -1.48M | -106.27% |
Free cash flow | -8.09M | -37.18% |
About
Founded
2011
Headquarters
Website
Employees
32
